α-Helical-corticotropin-releasing hormone reverses anxiogenic effects of C-type natriuretic peptide in rats

Brain Research

Volumn 893, Issue 1-2, 2001, Pages 21-28

  Jahn, Holger ^a   Montkowski, Alexandra ^b   Knaudt, Kristina ^a   Ströhle, Andreas ^b   Kiefer, Falk ^a   Schick, Mildred ^a   Wiedemann, Klaus ^a  

^a UNIVERSITY OF HAMBURG   (Germany)

^b MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

Author keywords

Anxiety; Atrial natriuretic peptide; C type natriuretic peptide; Corticotropin releasing hormone; Elevated plus maze; HPA system; Natriuretic peptides

Indexed keywords

ALPHA HELICAL CORTICOTROPIN RELEASING FACTOR ANTAGONIST; ATRIAL NATRIURETIC FACTOR; CORTICOSTERONE; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR ANTAGONIST; CORTICOTROPIN RELEASING FACTOR RECEPTOR; NATRIURETIC PEPTIDE TYPE C; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANXIETY; ARTICLE; BEHAVIOR; BRAIN REGION; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; HORMONE BLOOD LEVEL; MALE; NEUROENDOCRINE SYSTEM; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR OCCUPANCY; TASK PERFORMANCE; TRANQUILIZING ACTIVITY;

ADRENOCORTICOTROPIC HORMONE; ANIMALS; ANXIETY; BEHAVIOR, ANIMAL; CORTICOSTERONE; CORTICOTROPIN-RELEASING HORMONE; DOSE-RESPONSE RELATIONSHIP, DRUG; HORMONE ANTAGONISTS; INJECTIONS, INTRAVENTRICULAR; MALE; MAZE LEARNING; NATRIURETIC PEPTIDE, C-TYPE; RATS; RATS, WISTAR; REACTION TIME;

EID: 0035793950     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(00)03275-3     Document Type: Article

References (50)

1. The effects of CRF and α-helical CRF on anxiety in normal and hypophysectomized rats
2. The role of corticotropin-releasing factor in depression and anxiety disorders
3. CRF antagonist reverses the "anxiogenic" response to ethanol withdrawal in the rat
4. C-type natriuretic peptide
5. Corticotropin-releasing factor antagonist attenuates the "anxiogenic-like" effect in the defensive burying paradigm but not in the elevated plus-maze following chronic cocaine in rats
6. Behavioral effects of atrial natriuretic and brain natriuretic peptides in rats
7. Influence of exogenous atrial natriuretic peptide on the pituitary-adrenal response to corticotropin-releasing hormone and vasopressin in healthy men
8. 1-28) on corticotropin releasing factor in brain of rats
9. Effect of receptor blockers on brain natriuretic peptide and C-type natriuretic peptide caused anxiolytic state in rats
10. Central C-type natriuretic peptide but not atrial natriuretic factor lowers blood pressure and adrenocortical secretion in normal conscious sheep
11. Effect of corticotrophin-releasing hormone on arginine vasopressin and atrial natriuretic factor in patients with Cushing's disease
12. 9-41
13. Activation of the locus coeruleus noradrenergic system by intracoerulear microinfusion of corticotropin-releasing factor: Effects on discharge rate, cortical norepinephrine levels and cortical electroencephalographic activity
14. Use of the elevated plus maze in the search for novel anxiolytic agents
15. Atriopeptins are potent inhibitors of ACTH secretion by rat anterior pituitary cells in vitro: Involvement of the atrial natriuretic factor receptor domain of membrane-bound guanylyl cyclase
16. Atrial natriuretic peptide is a physiological inhibitor of ACTH release: Evidence from immunoneutralization in vivo
17. Atrial natriuretic peptide in the locus coeruleus and its possible role in the regulation of arterial blood pressure, fluid and electrolyte homeostasis
18. Expression and glucocorticoid regulation of natriuretic peptide clearance receptor (NPR-C) mRNA in rat brain and choroid plexus
19. Corticotropin-releasing factor antagonist reduces emotionality in socially defeated rats via direct neurotropic action
20. Atrial natriuretic peptides inhibit the release of corticotropin-releasing factor-41 from the rat hypothalamus in vitro
21. Effects of C-type natriuretic peptide on pituitary-adrenal activation in rats
22. Central non-glucocorticoid inhibitors of the hypothalam-pituitary-adrenal axis
23. C-type natriuretic peptide (CNP) is the major natriuretic peptide in human cerebrospinal fluid
24. Atrial natriuretic factor inhibits the CRH-stimulated secretion of ACTH and cortisol in man
25. Possible role of atrial natriuretic hormone in pituitary-adrenocortical unresponsiveness in lactate-induced panic
26. C-type natriuretic peptide exerts stimulatory effects on the corticotropin-releasing hormone-induced release of hormones in normal man
27. Hydrolysis of human and pig brain natriuretic peptides, urodilatin, C-type natriuretic peptide and some C-receptor ligands by endopeptidase-24.11
28. Physiological concentrations of atrial natriuretic factors with intact N-terminal sequences inhibit corticotropin-releasing factor-stimulated adrenocorticotropin secretion from cultured anterior pituitary cells
29. Selective activation of the B natriuretic peptide receptor by the C-type natriuretic peptide (CNP)
30. Distribution of natriuretic peptide precursor mRNA in the rat brain
31. ANP (5-28) is the major molecular species in hypophysial portal blood of the rat
32. Chromosomal distribution of three members of the human natriuretic peptide receptor/guanylyl cyclase gene family
33. Receptors of atrial natriuretic factor
34. C-type natriuretic peptide exerts effects opposing those of atrial natriuretic peptide on anxiety-related behavior in rats
35. Atrial natriuretic factor in central cardiovascular control
36. Behavioral effects of atriopeptin in rats
37. Natriuretic peptides: A family of hormones
38. Atrial natriuretic factor inhibits dehydration and hemorrhage-induced vasopressin release
39. Further evidence for a hypothalamic site of action of atrial natriuretic factor: Inhibition of prolactin secretion in the conscious rat
40. Central peptidergic mechanisms controlling reproductive hormone secretion: A novel methodology reveals a role for the natriuretic peptides
41. CNP-22 stimulates, rather than inhibits, water drinking in the rat: Evidence for an unique biological action of the C-type natriuretic peptides
42. Autonomic reactivity and hormonal secretion in lactate-induced panic attacks
43. Central and peripheral administration of atriopeptin is anxiolytic in rats
44. Atrial natriuretic hormone decreases endocrine response to a combined dexamethasone-corticotropin-releasing hormone test
45. Release of immunoreactive atrial natriuretic factor from rat hypothalamus in vitro
46. C-type natriuretic peptide neuromodulates via "clearance" receptors
47. Atrial natriuretic factor enhances norepinephrine uptake in circumventricular organs, locus coeruleus and nucleus tractus solitarii of the rat
48. Effects of natriuretic peptides upon HPA system activity and anxiety behavior
49. Differential regional expression of three natriuretic peptide receptor genes within primate tissues